MICROPORT (00853): Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (688016.SH) saw its net profit attributable to shareholders decrease by 22.46% to approximately 429 million yuan in the first three quarters.

20:15 29/10/2025

MicroPort Medical (00853) announced the performance of Heartway Medical (688016.SH) in the first three quarters of 2025, with operating...

MICROPORT (00853) announces the performance of Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (688016.SH) in the first three quarters of 2025. The operating income is approximately 1.015 billion yuan, an increase of 4.66% year-on-year; the net profit attributable to the shareholders of the listed company is approximately 429 million yuan, a decrease of 22.46% year-on-year; and the basic earnings per share is 3.54 yuan.

CHINARES PHARMA (03320) leads the establishment of a 500 million fund, focusing on synthetic biology and innovative drug fields.

China Longyuan Power Group Corporation (00916) will distribute a mid-term dividend of HK$0.1096 per share on December 30th.

Galaxy Securities: "The 15th Five-Year Plan" opens a new chapter, the semiconductor industry welcomes strategic new opportunities, closely following the breakthrough in the entire chain and the domestic substitution trend.

CHINARES PHARMA (03320) leads the establishment of a 500 million fund, focusing on synthetic biology and innovative drug fields.

China Longyuan Power Group Corporation (00916) will distribute a mid-term dividend of HK$0.1096 per share on December 30th.